Drug
sevabertinib
Marketed as HYRNUO.
Generic name
sevabertinib
Brand names
HYRNUO
First FDA approval
2025-11-19
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA219972 | HYRNUO | 2025-11-19 | BAYER HEALTHCARE |
Manufacturers
BAYER HEALTHCARE
Frequently asked questions
When was sevabertinib FDA approved?
Earliest FDA approval on record: 2025-11-19.
What brand names are sold as sevabertinib?
HYRNUO.
Sources
Appeal a sevabertinib denial
Upload the denial notice. DenialHelp helps verify the reason, organize source-linked evidence, and prepare a treating-clinician-reviewable package. Price and refund terms are shown before payment.
Get started →Contact: hello@denialhelp.com